Herpes Simplex Encephalitis (HSV-2 type)
What is Herpes Simplex Encephalitis (HSV-2 type)?
Herpes simplex encephalitis is a rare but serious brain infection caused by the herpes simplex virus. While HSV-1 causes most cases, HSV-2 can also infect the brain, especially in newborns and people with weakened immune systems. This infection happens when the virus travels from its usual sites to the brain tissue, causing inflammation.
The condition is a medical emergency that requires immediate treatment. Without prompt care, it can cause permanent brain damage or death. HSV-2 encephalitis is less common than HSV-1 encephalitis in adults but represents a significant risk in certain populations. Early detection and treatment with antiviral medications can save lives and reduce long-term complications.
Blood tests can help identify whether HSV-2 is present in your system. This information helps doctors determine the cause of brain inflammation and choose the right treatment approach. Knowing your HSV-2 status is particularly important for pregnant women, as the virus can pass to babies during birth.
Symptoms
- Sudden high fever above 101°F
- Severe headache that does not respond to pain relievers
- Confusion or altered mental state
- Seizures or convulsions
- Difficulty speaking or understanding speech
- Weakness or paralysis on one side of the body
- Behavioral changes or personality shifts
- Sensitivity to light
- Stiff neck or neck pain
- Loss of consciousness or coma in severe cases
In newborns, symptoms may include poor feeding, irritability, lethargy, and bulging soft spots on the skull. Some people may have mild symptoms initially that rapidly worsen within hours or days. Early recognition of symptoms is critical for survival and recovery.
Concerned about Herpes Simplex Encephalitis (HSV-2 type)? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
HSV-2 encephalitis occurs when the herpes simplex virus type 2 invades brain tissue. In newborns, infection typically happens during vaginal delivery when a mother has active genital herpes. In adults, the virus can reactivate from nerve cells where it stays dormant and travel to the brain. People with weakened immune systems face higher risk, including those with HIV, cancer patients undergoing chemotherapy, and organ transplant recipients taking immune-suppressing drugs.
Risk factors include having genital herpes infections, immunosuppression from disease or medication, and being a newborn exposed during birth. Stress, illness, and immune system changes can trigger viral reactivation. Unlike HSV-1 encephalitis, which often occurs in otherwise healthy people, HSV-2 brain infections are more strongly linked to immune system problems. Pregnant women with first-time HSV-2 infections near delivery time pose the greatest risk to their babies.
How it's diagnosed
Doctors diagnose herpes simplex encephalitis using brain imaging, spinal fluid analysis, and blood tests. An MRI or CT scan can show brain inflammation in specific areas. A lumbar puncture collects cerebrospinal fluid, which is tested for HSV DNA using a PCR test. Blood tests like the HSV-2 IgG antibody test help determine if you have been exposed to the virus and can help distinguish HSV-2 from HSV-1 as the cause.
Rite Aid offers HSV-2 IgG testing as an add-on to our preventive health panel. This blood test detects antibodies your body makes in response to HSV-2 infection. While diagnosing active encephalitis requires emergency medical care and specialized testing, knowing your HSV-2 status helps with risk assessment and preventive planning. Early diagnosis of encephalitis is critical, as treatment must begin within hours to prevent permanent damage.
Treatment options
- Immediate intravenous antiviral medication, usually acyclovir, for 14 to 21 days
- Hospital intensive care unit monitoring for severe cases
- Anti-seizure medications to control convulsions
- Medications to reduce brain swelling and pressure
- Breathing support with ventilator if needed
- Physical therapy and rehabilitation after acute phase
- Speech therapy for language and communication recovery
- Occupational therapy to regain daily living skills
- Long-term antiviral suppression therapy in some cases
- Counseling and mental health support for cognitive and emotional changes
Need testing for Herpes Simplex Encephalitis (HSV-2 type)? Add it to your panel.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
HSV-1 causes about 90% of herpes encephalitis cases in adults and typically affects previously healthy people. HSV-2 encephalitis is rarer and mainly affects newborns and people with weakened immune systems. Both types cause similar brain inflammation, but knowing which virus is responsible helps doctors understand transmission risk and plan long-term care.
Symptoms can develop rapidly over hours to a few days. Early signs include fever and headache, which quickly progress to confusion, seizures, and altered consciousness. This is a medical emergency requiring immediate hospital care. The faster treatment begins, the better the chances of recovery without permanent brain damage.
Blood tests like HSV-2 IgG show past or current infection but cannot diagnose active brain inflammation alone. Active encephalitis requires spinal fluid testing for viral DNA and brain imaging. However, blood tests help doctors identify which herpes virus type you carry and assess your risk factors.
The encephalitis itself is not contagious, but the herpes virus can spread to others through direct contact. HSV-2 typically spreads through sexual contact or from mother to baby during birth. If you have HSV-2, you can transmit the virus even without active symptoms, though the risk is lower.
Many survivors experience lasting neurological problems including memory loss, difficulty concentrating, personality changes, and language problems. Some people have ongoing seizures requiring medication. Physical disabilities like weakness or coordination problems may persist. Early treatment with antivirals significantly improves outcomes and reduces the severity of long-term effects.
Pregnant women with known HSV-2 should take antiviral medication in the last weeks of pregnancy to reduce viral shedding. If active genital lesions are present at delivery, a cesarean section prevents transmission during vaginal birth. Regular prenatal care and honest communication with your doctor about herpes status are essential for protecting your baby.
Newborns exposed during birth, people with HIV or AIDS, cancer patients receiving chemotherapy, and organ transplant recipients face the highest risk. People taking medications that suppress the immune system are also vulnerable. Adults with healthy immune systems rarely develop HSV-2 encephalitis, though it can happen.
Recurrent herpes encephalitis is rare but possible, especially in people with ongoing immune system problems. Most cases occur as a single episode. Taking long-term antiviral medication can prevent reactivation in high-risk individuals. Regular follow-up with neurologists and infectious disease specialists helps monitor for recurrence.
Without treatment, herpes encephalitis is fatal in about 70% of cases. With prompt antiviral therapy, survival rates improve to 70% to 80%. However, many survivors have permanent neurological damage. Starting treatment within the first 48 hours of symptoms gives the best chance for recovery with minimal lasting effects.
Testing makes sense if you are pregnant, planning pregnancy, have multiple sexual partners, or have a weakened immune system. Knowing your status helps you take preventive steps to protect others and yourself. Rite Aid offers convenient HSV-2 IgG testing as an add-on to our preventive health panel at Quest Diagnostics locations nationwide.